Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 4/2004

01-12-2004 | CASE REPORT

A case of Wegener’s granulomatosis with pulmonary bleeding successfully treated with double filtration plasmapheresis (DFPP)

Authors: Hirotsugu Iwatani, Takashi Uzu, Masahiro Kakihara, Yuji Nakayama, Keizo Kanasaki, Masaya Yamato, Yasuhiro Hirai, Koichi Umimoto, Atsushi Yamauchi

Published in: Clinical and Experimental Nephrology | Issue 4/2004

Login to get access
Metadata
Title
A case of Wegener’s granulomatosis with pulmonary bleeding successfully treated with double filtration plasmapheresis (DFPP)
Authors
Hirotsugu Iwatani
Takashi Uzu
Masahiro Kakihara
Yuji Nakayama
Keizo Kanasaki
Masaya Yamato
Yasuhiro Hirai
Koichi Umimoto
Atsushi Yamauchi
Publication date
01-12-2004
Publisher
Springer-Verlag
Published in
Clinical and Experimental Nephrology / Issue 4/2004
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-004-0321-z

Other articles of this Issue 4/2004

Clinical and Experimental Nephrology 4/2004 Go to the issue

ORIGINAL ARTICLE

Adrenomedullin (AM) and receptor-activity-modifying proteins in glomeruli with Thy.1 glomerulonephritis

CASE REPORT

Observe and be guarded: the development and rupture of an abdominal aortic mycotic aneurysm in an afebrile hemodialysis patient with normal angiogram, and CT scan, and sterile blood cultures

CASE REPORT

Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse

ORIGINAL ARTICLE

An example of social activities by registered dietitians: development of recipes for cook-chilled meals to be delivered to kidney disease patients in the conservative treatment and maintenance dialysis stages

ORIGINAL ARTICLE

Interaction of the spectrin-like repeats of alpha-actinin-4 with humanin peptide

ORIGINAL ARTICLE

Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits